No Detail Found!

In Vitro effect of New Antibiotics against Clinical Isolates of Salmonella Paratyphi A.

Author(s)
Nasrullah Malik Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Muneeb Ur Rehman Combined Military Hospital Lahore, Pakistan
Mamoon Ahmed Army Medical College/ National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Abstract
Objective: The objective of this study was to determine in vitro MIC patterns of various therapeutic alternatives for the treatment of Salmonella Paratyphi A. Study Design: Cross-sectional study. Place and Duration of Study: Armed Forces Institute of Pathology Rawalpindi, from Jun 2012 to May 2014. Material and Methods: Clinical samples were collected from suspected cases of salmonella infections. Culture was applied on Bactec 9050 special and/or standard media. Suspected Salmonella Paratyphi colonies were tested by API 20E and confirmed by serology. The isolates were also tested for resistance to ampicillin, cotrimoxazole, ciprofloxacin, ceftriaxone, doripenem, imipenem, ertapenem, aztreonam, moxifloxacin, cefpirome, cefepime, gatifloxacin, and chloramphenicol by Kirby-Bauer disc diffusion method. MIC (Minimum Inhibitory concentration) was done on MDR and ciprofloxacin intermediate or resistant cases by E-strips. Results: One hundred and eleven isolates of Salmonella Paratyphi were recovered from 2230 specimens. Resistance by disk diffusion technique noted in Salmonella Paratyphi A was ampicillin 60%, chloramphenicol 40%, cotrimoxazole 38%, ceftriaxone 7.9%, ciprofloxacin 8%, cefpodoxime 7.9%, imipenem and ertapenem 2.6%, aztreonam 1.3%, moxifloxacin 6.6%, and gatifloxacin 1.3%. No resistance was noted for doripenem and cefepime. MIC50 was 0.094 for Cefpirome, 0.125 Aztreonam, 0.25 imipenem and tigecycline, 2 cefpodoxime and 8 for azithromycin. Conclusion: Azithromycin, Aztreonam, Imipenem, tygecycline, cefpodoxime and cefpirome are potential therapeutic agents for resistant Salmonella Paratyphi A infections.
Publication Details
Page(s) 254-260
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 2, Year: 2018

Request the full text from PASTIC

References
HabermannET,FriedenthalRB, 1978.Septic arthritis associated with avascular necrosis of the femoral head,Clin Orthop Relat Res 134 325 -31
ThongKL,NairS,ChaudhryR,SethP,KapilA,KumarD, 1998.Molecular analysis of Salmonella paratyphi a from an outbreak in New Delhi, India,Emerg Infect Dis 4 507 -8
SahaSK,TalukderSY,IslamM,Saha S, 1999.A highly ceftriaxoneresistant Salmonella typhi in Bangladesh,Pediatr Infect Dis J 18 387 -
.Background document. The diagnosis, treatment and prevention of typhoid fever,Geneva; 2003 -
GuptaV,KaurJ,KaisthaN., 2009.Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India,Trop Doct 39 28 -30
PrajapatiB,RaiGK,RaiSK,UpretiHC,ThapaM,SinghG, 2008.Prevalence of Salmonella typhi and paratyphi infection in children: a hospital based study,Nepal Med Coll J 10 238 -41
CapoorMR,NairD,HasanAS,AggarwalP,GuptaB, 2006.Typhoid fever: Narrowing therapeutic options in India,Southeast Asian J Trop Med Public Health 37 1170 -4
LunguyaO,LejonV,PhobaMF,BertrandS,VanhoofR,GlupczynskiY, 2013.Antimicrobial resistance in invasive nontyphoid salmonella from the democratic republic of the congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases,PLoS Negl Trop Dis 7 e2103 -
GunellM,KotilainenP,JalavaJ,HuovinenP,SiitonenA,HakanenAJ, 2010.In vitro activity of azithromycin against nontyphoidal Salmonella enterica,Antimicrob Agents Chemother 54 3498 -501
MolloyA,NairS,CookeFJ,WainJ,FarringtonM,LehnerPJ, 2010.First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure,J Clin Microbiol 48 4655 -7
Ellen Jo Baron Richard B Thomson, 2012.Specimen collection, transport and processing: Bacteriology,Manual of Clinical Microbiology 228 -71
WautersG,VaneechoutteM.,VersalovicJ,KarrollKC,FunkeG,JorgensonJH,LandryML, 2012.Approaches to the Identification of Aerobic Gram-Negative Bacteria,Manual of Clinical Microbiology 539 -58
Grimont, 2007.Antigenic formulae of the Salmonella Serovars, -
BauerAW,KirbyWM,SherrisJC,TurckM., 1966.Antibiotic susceptibility testing by a standardized single disk method,Am J Clin Pathol 45 493 -6
CLSI, 2012.Performance standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Suppliment, M100 -S22
2013.Breakpoint tables for interpretation of MICs and zone diameters,Ver 3 -
ButlerT., 2001.Effect of increased inoculum of Salmonella typhi on MIC of azithromycin and resultant growth characteristics,J Antimicrob Chemother 48 903 -6
.US Food and Drug Administration. FDA drug safety communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new boxed warning 2017, -
QaiserS,IrfanS,KhanE,AhsanT,ZafarA., 2011.In Vitro Susceptibility of typhoidal Salmonellae against newer antimicrobial agents: A search for alternate treatment options,J Pak Med Assoc 61 462 -5
ChinhNT,ParryCM,LyNT,HaHD,ThongMX,DiepTS, 2000.A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acidresistant enteric fever,Antimicrob Agents Chemother 44 1855 -9
FrenckRW,NakhlaI,SultanY,BassilySB,GirgisYF,DavidJ, 2000.Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children,Clin Infect Dis 31 1134 -8
ShanahanPM,KaramatKA,ThomsonCJ,AmyesSG, 2000.Characterization of multi-drug resistant salmonella typhi isolated from Pakistan,Epidemiol Infect 124 9 -16
ArletG,BarrettTJ,ButayeP,CloeckaertA,MulveyMR,WhiteDG, 2006.Salmonella resistant to extended-spectrum cephalosporins: Prevalence and epidemiology,Microbes Infect 8 1945 -54
2010.Georgia: US department of health and, -
MathaiD,RhombergPR,BiedenbachDJ,JonesRN, 2002.Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: A survey of ten medical center laboratories,Diagn Microbiol Infect Dis 44 367 -77
FritscheTR,StrabalaPA,SaderHS,DowzickyMJ,JonesRN, 2005.Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates,Diagn Microbiol Infect Dis 52 209 -13
0

Citations

0

Downloads

102

Views